The Latest Cardiac and Vascular News
GOTHENBURG, Sweden, Jan. 17, 2022 /PRNewswire/ — Getinge appoints Patricia Fitch as President North America Region. Patricia succeeds Eric Honroth who has been appointed President Life Science at Getinge. Patricia Fitch joined Getinge in March 2021 as Vice President US Sales covering the Acute Care Therapies division. Patricia has more than 30 years of medical device experience, having held leadership […]
GREENVILLE, S.C.–(BUSINESS WIRE)–Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the formation of its Scientific Advisory Board. The Board is comprised of leading industry and university experts in cardiovascular research and clinical development. Former […]
GETINGE, Sweden, Jan. 17, 2022 /PRNewswire/ — Getinge appoints new Presidents for two business areas and members of the Executive team. Elin Frostehav is appointed President Acute Care Therapies and Eric Honroth President Life Science starting April 1, 2022. Elin Frostehav has been appointed President Acute Care Therapies and member of the Getinge Executive team. […]
CHICAGO, Jan. 17, 2022 (GLOBE NEWSWIRE) — Today, Dr. Nathan S. Bryan, world-renowned molecular medicine and nitric oxide expert and founder of Pneuma Nitric Oxide, LLC and Bryan Nitriceuticals, LLC, announced a partnership with Berkeley Life, a practitioner-exclusive nitric oxide nutraceutical brand. Dr. Bryan and Berkeley Life share a mission […]
Complementary technology to orbital atherectomy expands CSI’s vessel prep market opportunity ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today it has made significant progress towards the commercialization of […]
The objective of this study is to obtain data on the technical feasibility, safety, and efficacy of the second-generation eCLIPs products for the treatment of bifurcation aneurysms. VANCOUVER, British Columbia–(BUSINESS WIRE)–Evasc Neurovascular, a pioneer in the development of disruptive endovascular treatments for cerebral aneurysms, announced today the enrollment of the […]
Two novel targets identified through the existing collaboration have already been added to AstraZeneca’s portfolio LONDON, Jan. 13, 2022 /PRNewswire/ — BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca, doubling the number of disease areas being explored through the partnership. The three-year expansion includes an […]
CARLSBAD, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the company’s attendance at the 27th Annual AF Symposium. Cases performed at Na Homolce Hospital in Prague, Czech Republic, by physicians Jacob […]
NDA submitted for sotagliflozin in heart failure with an expected launch in 2H 2022, if approved LX9211 neuropathic pain Phase 2 studies expected to read out in 1H 2022 THE WOODLANDS, Texas, Jan. 13, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) is outlining major potential value drivers for 2022 at […]
BOSTON, Jan. 13, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC) today announced the appointment of the independent member June Lee, M.D. to the company’s Board of Directors. Dr. Lee brings decades of leadership experience in the biotechnology and pharmaceutical industry and has served in numerous executive and board […]
